Neurologic Emergencies in Cancer Patients
Neurol Clin 16:1-37, Schiff,D.,et al, 1998
Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Calcium-Channel Antibodies in the Lambert-Eaton Syndrome and Other Paraneoplastic Syndromes
NEJM 332:1467-1474, Lennon,V.A.,et al, 1995
Trends in the Association of Lambert-Eaton Myasthenic Syndrome with Carcinoma
Neurol 42:848-850, Gutmann,L.,et al, 1992
Calcium Channel Autoantibodies in the Lambert-Eaton Myashenic Syndrome
Ann Neurol 29:307-314, Leys,K.,et al, 1991
Adverse Drug Effects on Neuromuscular Transmission
Semin Neurol 10:89-102, Howard,J.F., 1990
Specificity of Calcium Channel Autoantibodies in Lambert-Eaton Myasthenic Syndrome
Lancet 2:640-643, Sher,E.,et al, 1989
Autoantibody Activity in Lambert-Eaton Myasthenic Syndrome
Editorial, Lancet 1:9201988., , 1988
The Neurotoxicity of Antibacterial Agents
Ann Int Med 101:92-104, Snavely,S.R.,et al, 1984
Myasthenia Gravis & Myasthenic Syndromes
Ann Neurol 16:519-534, Engel,A.G., 1984
Treatment with Oral 4-aminopyridine in Disorders of Neuromuscular Transmission
Neurol 31:265-271, Murray,N.M.F.,et al, 1981